Rocket Lab Corporation (NASDAQ: RKLB) is drawing significant attention from derivatives traders ahead of its first quarter 2026 earnings announcement on 7 May, with options pricing implying a post-results move of approximately 13.88 percent in either direction. That figure is nearly three times larger than the company’s average earnings day swing of 4.65 percent over the preceding four quarters, signalling that market participants expect a meaningful reaction regardless of which way the numbers break.
The elevated implied move reflects both the ambition embedded in the company’s own guidance and the high valuation multiples the stock currently carries. RKLB is trading at enterprise value to sales multiples that sit 20 to 30 times above sector medians, a premium that demands consistent execution on the growth story Rocket Lab has been building.
Revenue guidance for Q1 2026 points to a range of $185 million to $200 million, which would represent year over year growth of approximately 57 percent. GAAP gross margin is expected to land between 34 and 36 percent, while non-GAAP gross margin guidance sits at 39 to 41 percent. Adjusted EBITDA loss guidance of $21 million to $27 million reflects the ongoing investment cycle the company is managing, particularly around the Neutron launch vehicle programme.
The options chain for expiry around the earnings date shows open interest concentrated near the $105 call strike and the $75 put strike, with max pain estimated at approximately $78. The put to call ratio sits at roughly 0.77, suggesting the market leans modestly bullish heading into the announcement, though the broad spread of positioning reflects genuine uncertainty.
Rocket Lab ended 2025 with a record order backlog of $1.85 billion, providing a substantial buffer of contracted future work. The company also held approximately $1.1 billion in liquidity at the end of the fourth quarter, having raised $280.6 million through at-the-market equity issuance in recent months.
Progress on the Neutron medium lift vehicle will be a key focus for analysts during the post-results conference call. A Stage 1 tank rupture during testing pushed the first launch window back to late 2026 or early 2027, but Rocket Lab has confirmed that qualification milestones on major hardware components are being met, and the Archimedes engine test programme is advancing toward flight readiness.
Wall Street consensus on RKLB stands at a Moderate Buy, with nine Buy ratings and four Hold recommendations issued across the past three months.
Timothy Mason is a senior reporter at the Foreign Policy Journal, covering current affairs and business news. He studied Economics at the University of Michigan and has worked as a journalist for over seven years.
